Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Chamelli Jhappan, Ph.D.

Program Director
Division of Cancer Biology (DCB)
Cancer Immunology, Hematology, and Etiology Branch
240-276-6220
|
jhappanc@mail.nih.gov

Dr. Chamelli Jhappan has expertise in oncogenic RNA viruses, hematopoietic malignancies, multidrug resistance in cancer, and nervous system regulation of cancer. She manages a portfolio of grants focusing on hematological malignancies, such as leukemia and lymphoma.

Along with her DCB responsibilities, Dr. Jhappan is also a member of the trans-NCI Aging and Cancer Committee and the Pancreatic Cancer Action Planning Group.

 

Research Programs

Dr. Jhappan also manages a DCB research program and is also involved in an NIH Common Fund program:

 

Background

Prior to DCB, Dr. Jhappan worked as a staff scientist in a molecular biology laboratory in the Intramural Research Program (IRP) of NIH.  

She came to DCB to help move science forward and to be able to interact with cancer researchers. Dr. Jhappan says “encouraging and informing the research community of what’s going on in other fields helps us take more efficient approaches to research.”

 

Education

  • Ph.D, Biochemistry, Georgetown University 


     
 

Email